COVID-19 vaccine to have differential pricing: Pfizer

By: |
December 9, 2020 7:37 PM

The company’s Indian arm has sought emergency use authorisation (EUA) for the Pfizer/BioNTech vaccine against COVID-19 in the country from the Indian drug regulator.

Pfizer is in talks with various governments for the vaccine.

Global pharma major Pfizer has said it will have differential pricing on its COVID-19 vaccine for different countries, as the company aims to make the vaccine available across the world.

The company’s Indian arm has sought emergency use authorisation (EUA) for the Pfizer/BioNTech vaccine against COVID-19 in the country from the Indian drug regulator.

After the UK approval for the vaccine, Pfizer and BioNTech are anticipating further regulatory decisions across the globe in the coming days and are ready to deliver vaccine doses following potential regulatory authorisations or approvals,” Pfizer had earlier said.

“The fundamental that went into the pricing was that we make sure we make it very quickly available to everyone,” Pfizer Inc Chairman and CEO Albert Bourla said at a virtual press conference organised by International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) on Tuesday.

“We are having a tier pricing. It is one price for the developed world based on their GDP, another price, lower for the middle-income countries and in the low-income countries, like countries in Africa etc we are giving it on a not-on-profit base,” he added.

Even in developed countries, the price is what they can afford to pay. In the US the price is USD 19.50, the price of an average meal, Bourla said.

The company is in talks with various governments for the vaccine, he added.

Bourla also said the company is also working on a new formulation that will be able to avoid the -70 degree requirement and can be stored in simple refrigeration.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1India has flattened its COVID-19 graph; 146 districts have no new cases for 7 days: Harsh Vardhan
2Progress in family planning can strengthen women’s contribution to India’s economic growth
3Neighbourhood First in Vaccine maitri: Sri Lanka receives COVISHIELD vaccines